For the second year in a row, our Managing Director Cesar Carnicer was interviewed by Joseph Harvey (Animal Pharm), business analyst for IHS Markit.
For sure, in these times of pandemic, we all need to read, hear and talk about things that are going well and bring a little positivity to our daily lives. Although we are rather discreet on the subject, for once we are going to talk about Syva from a more ‘business’ angle.
As this economic analyst’s evocatively titled article points out: ‘Syva’s investment in burgeoning vaccine business undeterred by pandemic’, Syva has remained solid despite the sanitary threat and has been well advised to continue developing its vaccine production activities, which now account for a third of its turnover and which reached a decisive turning point in 2019 with the launch of its multi-strain vaccine against blue tongue disease.
If we had to give some achievements of Syva’s activity in 2020, it is
- A growing turnover;
- A storage capacity that has almost doubled;
- A storage capacity linked to the cold chain dedicated to vaccines that has tripled;
- The establishment of a new subsidiary in Turkey which opens up new horizons;
- The perspective of launching new vaccines that will strengthen its own product portfolio with high focus on quality.
These are all reasons and opportunities to renew its commitment to its customers by keeping its focus on its mission to offer ‘meaningful solutions for animal health’.
More details in the interview with César Carnicer, CEO of Syva, by Joseph Harvey (Animal Pharm) for IHS Markit: Syvas_investment_in_burgeoning_vaccine_business_undeterred_by_pandemic-2
For more information on IHS Markit: https://ihsmarkit.com/company/index.html
For more information on Syva: www.syva.es/en
You may also be interested in
23 October, 2023
Syva goes one step further in its commitment to the protection of the environment
Syva confirms its commitment to the environment by taking a giant step towards greater energy efficiency with the installation of more than 3,000 square metres of photovoltaic panels on the roofs of its production centre. And on Friday 20 October it started producing its first kilowatts of electricity.
22 September, 2023
Azucena Mora, winner of the Syva Award 2003, achieves the highest academic level
It has been an impressive journey since 2003, when she submitted her thesis and, as a young doctor, won the Syva Award. Since then, their paths have regularly crossed with those of our colleagues. Her testimonial as a winner and as a member of the panel of the jury for the 25th edition of the Award in 2022 and...
30 August, 2023
New tool for controlling erysipelas and PPV: Syvac® Ery Parvo
Because every farm is unique, it needs individualised protocols for swine erysipela and PPV control. Failing to control erysipelas and PPV throughout a sow's life can lead to a host of problems that are difficult to control and have a direct impact on production.